Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02420509 · ClinicalTrials.gov registry record
Postoperative Chemotherapy in High-Grade Appendiceal Adenocarcinoma With Peritoneal Carcinomatosis
A clinical trial, sponsored by University of California, San Diego.
- Terminated
- Registry status
- 2
- Enrollment target
NCT02420509 is a clinical trial that was terminated before completion, run by University of California, San Diego. The registered enrollment target is 2 participants.
The verdict
NCT02420509 was terminated before completion, sponsored by University of California, San Diego.
- TERMINATED
- Registry status
- 2 participants
- Enrollment target
Study Summary
The purpose of this study is to find out if postoperative chemotherapy in patients with high-grade appendix cancer after surgery improves outcomes. The postoperative chemotherapy will consist of 5-FU (with leucovorin) or capecitabine with bevacizumab. These drugs are approved for use in people with colon cancer, and they are used at UCSD for some patients with appendix cancer. The purpose of this study is to explore the safety and efficacy of the postoperative chemotherapy treatment on cancer.
Interventions
- DRUG systemic chemotherapy
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 2 participants |
| Start Date | 2015-08-27 |
| Est. Completion | 2019-04-02 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02420509
The ClinicalTrials.gov registry entry for NCT02420509 describes a study currently listed as terminated, categorized as an unspecified phase. The registered enrollment target is 2 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of California, San Diego, which has 775 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which systemic chemotherapy is the first listed.
NCT02420509 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02420509 about?
NCT02420509 is a clinical study titled "Postoperative Chemotherapy in High-Grade Appendiceal Adenocarcinoma With Peritoneal Carcinomatosis". The purpose of this study is to find out if postoperative chemotherapy in patients with high-grade appendix cancer after surgery improves outcomes. The postoperative chemotherapy will consist of 5-FU (with leucovorin) or capecitabine with bevacizumab. These drugs are approved for use in people with...
What is the current status of trial NCT02420509?
This trial is currently terminated. The enrollment target is 2 participants. The study started on 2015-08-27. Estimated completion is 2019-04-02.
What interventions are being tested in trial NCT02420509?
The interventions under investigation include: systemic chemotherapy (DRUG).
Who is sponsoring clinical trial NCT02420509?
This trial is sponsored by University of California, San Diego, which has 775 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.